The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells

被引:355
|
作者
Shevach, Ethan M. [1 ]
DiPaolo, Richard A. [1 ]
Andersson, John [1 ]
Zhao, Dong-Mei [1 ]
Stephens, Geoffrey L. [1 ]
Thornton, Angela M. [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
autoimmune gastritis; regulatory T cells;
D O I
10.1111/j.0105-2896.2006.00415.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous studies over the past 10 years have demonstrated the importance of naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells (nTregs) in immune regulation. We analyzed the mechanism of action of nTregs in a well-characterized model of autoimmune gastritis and demonstrated that nTregs act at an early stage of disease progression to inhibit the differentiation of naive T cells to pathogenic T-helper 1 effectors. The effects of nTregs in this model are not antigen-specific but are mediated by activation of the nTregs by ubiquitous self-peptide major histocompatibility complex class II complexes together with cytokines released by activated effector cells. Studies in vitro confirmed that some nTregs exist in an activated state in vivo and can be activated to exert non-specific suppressor effector function by stimulation with interleukin-2 in the absence of engagement of their T-cell receptor. Natural Tregs can differentiate in vitro to exhibit potent granzyme B-dependent, partially perforin-independent cytotoxic cells that are capable of specifically killing antigen-presenting B cells. Natural Treg-mediated killing of antigen-presenting cells may represent one pathway by which they can induce long-lasting suppression of autoimmune disease.
引用
收藏
页码:60 / 73
页数:14
相关论文
共 50 条
  • [1] Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin
    Strauss, Laura
    Whiteside, Theresa L.
    Knights, Ashley
    Bergmann, Christoph
    Knuth, Alexander
    Zippelius, Alfred
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 320 - 329
  • [2] CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases
    Xavier Valencia
    Peter E Lipsky
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 619 - 626
  • [3] Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
    Battaglia, M
    Stabilini, A
    Roncarolo, MG
    [J]. BLOOD, 2005, 105 (12) : 4743 - 4748
  • [4] Characterization of CD4+CD25+foxp3+ regulatory T cells in psoriatic skin
    Gyulai, R.
    Kocsis, K.
    Varga, B.
    Kemény, L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 49 - 49
  • [5] CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice
    Nishioka, T.
    Iida, R.
    Shimizu, J.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 147 - 147
  • [6] CD4+CD25+Foxp3+ T cells and CD4+CD'25-Foxp3+ T cells in aged mice
    Nishioka, Tomohisa
    Shimizu, Jun
    Iida, Ryuji
    Yamazaki, Sayuri
    Sakaguchi, Shimon
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (11): : 6586 - 6593
  • [7] Inhibition of γδ T cell proliferation by CD4+CD25+FOXP3+ regulatory T cells (Treg).
    Kunzmann, Volker
    Kimmel, Brigitte
    Engert, Judith
    Wilhelm, Martin
    Einsele, Hermann
    [J]. BLOOD, 2006, 108 (11) : 494A - 494A
  • [8] IL-2 signaling and CD4+CD25+Foxp3+ regulatory T cells
    Turka, Laurence A.
    Walsh, Patrick T.
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1440 - 1446
  • [9] Frequency and function of CD4+CD25+FOXP3+ regulatory T cells in atopic dermatitis
    Gaspar, Krisztian
    Barath, Sandor
    Nagy, Georgina
    Gyimesi, Edit
    Sipka, Sandor
    Zeher, Margit
    Remenyik, Eva
    Szegedi, Andrea
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S40 - S40
  • [10] Functional deficit in CD4+CD25+Foxp3+ regulatory T cells in multiple sclerosis
    Zang, Ying C. Q.
    Hong, Jian
    Skinner, Sheri M.
    Zhang, Jingwu Z.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 195 - 195